NeuroScientific
NSB.AXNeuroScientific Biopharmaceuticals Limited Price (NSB.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
144,508,886
(0.723)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
NeuroScientific Biopharmaceuticals LimitedCurrency: AUD
| YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
116,000.00
+0% |
38,025.00
-67% |
28,876.00
-24% |
33,849.00
+17% |
0.00
+0% |
958,769.00
+0% |
0.00
+0% |
4,952,959.00
+0% |
0.00
+0% |
||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 0.00 | 9,892.00 | 42,983.00 | 55,205.00 | 56,661.00 | 61,407.00 | 64,915.00 | 57,854.00 | 91,337.00 | ||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
116,000.00
+0% |
28,133.00
-76% |
-14,107.00
-150% |
-21,356.00
+51% |
-56,661.00
+165% |
897,362.00
-1,684% |
-64,915.00
-107% |
4,895,105.00
-7,641% |
-91,337.00
-102% |
||||||||||
| Gross Profit Ratio | (1.00%) | (0.74%) | (-0.49%) | (-0.63%) | (0.00%) | (0.94%) | (0.00%) | (0.99%) | (0.00%) | ||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 232,804.00 | 75,516.00 | 730,421.00 | 1,422,717.00 | 2,217,944.00 | 7,220,142.00 | 4,026,118.00 | 492,459.00 | ||||||||||
| General and Administrative | 30,454.00 | 39,499.00 | 68,692.00 | 584,948.00 | 331,422.00 | 672,350.00 | 776,616.00 | 937,169.00 | 0.00 | ||||||||||
| Selling, General & Admin... | 219,068.00 | 288,832.00 | 842,214.00 | 865,914.00 | 1,462,006.00 | 1,944,291.00 | 3,218,742.00 | 2,040,388.00 | 1,472,762.00 | ||||||||||
| Selling & Marketing Exp... | 188,614.00 | 249,333.00 | 47,993.00 | 147,481.00 | 109,394.00 | 70,281.00 | 136,511.00 | 90,736.00 | 0.00 | ||||||||||
| Depreciation and Amortiz... | 103,068.00 | 9,892.00 | 42,983.00 | 55,205.00 | 56,661.00 | 61,407.00 | 64,915.00 | 57,854.00 | 91,337.00 | ||||||||||
| Other Expenses | 0.00 | 0.00 | 0.00 | 33,849.00 | 40,540.00 | 1,018,229.00 | 0.00 | 4,952,959.00 | 0.00 | ||||||||||
| Total Operating Expenses | 219,068.00 | 288,832.00 | 917,730.00 | 1,596,335.00 | 2,884,723.00 | 4,162,235.00 | 10,438,884.00 | 6,066,506.00 | 1,965,221.00 | ||||||||||
| Cost and Exponses | 219,068.00 | 298,724.00 | 960,713.00 | 1,651,540.00 | 2,941,384.00 | 4,223,642.00 | 10,503,799.00 | 6,124,360.00 | 2,056,558.00 | ||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-219,070.00
+0% |
-298,720.00
+36% |
-960,710.00
+222% |
-1,651,540.00
+72% |
-2,941,380.00
+78% |
-4,223,640.00
+44% |
-10,503,800.00
+149% |
-6,124,360.00
-42% |
-2,056,560.00
-66% |
||||||||||
| Operating Income Ratio | (-1.89%) | (-7.86%) | (-33.27%) | (-48.79%) | (0.00%) | (-4.41%) | (0.00%) | (-1.24%) | (0.00%) | ||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 25.00 | 418.00 | 417.00 | 85,437.00 | 35,733.00 | 27,645.00 | 68,450.00 | 107,529.00 | 178,936.00 | ||||||||||
| Interest Expenses | 344.00 | 578.00 | 125.00 | 0.00 | 3,417.00 | 63.00 | 0.00 | 4,734.00 | 0.00 | ||||||||||
| Total Other Income/Exp... | 115,683.00 | -418.00 | 417.00 | -75,071.00 | 72,856.00 | 87,043.00 | 68,450.00 | -4,850,164.00 | 168,941.00 | ||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -319.00 | -288,672.00 | -917,188.00 | -1,596,340.00 | -2,811,870.00 | -3,116,420.00 | -10,370,434.00 | -5,963,707.00 | -1,796,285.00 | ||||||||||
| EBITDA ratio | (-1.89%) | (-7.60%) | (-31.78%) | (-47.16%) | (0.00%) | (-4.34%) | (0.00%) | (-1.22%) | (0.00%) | ||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -103,387.00 | -299,142.00 | -960,296.00 | -1,692,762.00 | -2,868,528.00 | -3,177,831.00 | -10,435,349.00 | -6,021,565.00 | -1,887,619.00 | ||||||||||
| Income Before Tax Ratio | (-0.89%) | (-7.87%) | (-33.26%) | (-50.01%) | (0.00%) | (-3.31%) | (0.00%) | (-1.22%) | (0.00%) | ||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -319.00 | -38,025.00 | -28,876.00 | -33,849.00 | -1.00 | 3.00 | -5.00 | -4,952,959.00 | -2,211,829.00 | ||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -103,387.00
+0% |
-261,117.00
+153% |
-931,420.00
+257% |
-1,658,913.00
+78% |
-2,868,528.00
+73% |
-3,177,831.00
+11% |
-10,435,349.00
+228% |
-1,068,606.00
-90% |
324,210.00
-130% |
||||||||||
| Net Income Ratio | (-0.89%) | (-6.87%) | (-32.26%) | (-49.01%) | (0.00%) | (-3.31%) | (0.00%) | (-0.22%) | (0.00%) | ||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.00 | 0.00 | -0.03 | -0.02 | -0.04 | -0.02 | -0.07 | -0.01 | 0.00 | ||||||||||
| Diluted EPS | 0.00 | 0.00 | -0.03 | -0.02 | -0.04 | -0.02 | -0.07 | -0.01 | 0.00 | ||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 73,580,592.00 | 73,580,592.00 | 30,944,633.00 | 71,527,441.00 | 78,384,584.00 | 143,471,643.00 | 143,471,643.00 | 143,471,643.00 | 144,508,886.00 | ||||||||||
| Diluted Share Outstanding | 73,580,592.00 | 73,580,592.00 | 30,944,633.00 | 71,527,441.00 | 78,384,584.00 | 143,471,643.00 | 143,471,643.00 | 143,471,643.00 | 144,508,886.00 | ||||||||||